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Abstract
Objective—This study uses data from the largest effectiveness trial to date on treatment of co-
occurring posttraumatic stress and substance use disorders, using advances in statistical
methodology for modeling treatment attendance and membership turnover in rolling groups.
Method—Women receiving outpatient substance abuse treatment (N = 353) were randomized to
12 sessions of Seeking Safety or a health education control condition. Assessments were
completed at baseline and at 1 week, 3, 6, and 12 months posttreatment. Outcome measures were
alcohol and cocaine use in the prior 30 days captured using the Addiction Severity Index. Latent
class pattern mixture modeling (LCPMM) was used to estimate attendance patterns and to test for
treatment effects within and across latent attendance patterns and group membership turnover.
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Results—Across LCPMM analyses for alcohol and cocaine use, similar treatment attendance
patterns emerged: Completers never decreased below an 80% probability of attendance, droppers
never exceeded a 41% probability of attendance, and titrators demonstrated a 50% to 80%
probability of attendance. Among completers, there were significant decreases in alcohol use from
baseline to 1-week posttreatment, followed by nonsignificant increases in alcohol during follow-
up. No differences between treatment conditions were detected. Titrators in Seeking Safety had
lower rates of alcohol use from 1-week through 12-month follow-up compared with control
participants. Droppers had nonsignificant increases in alcohol during both study phases. Cocaine
use findings were similar but did not reach significance levels.
Conclusions—The impact of client self-modulation of treatment dosage and group membership
composition may influence behavioral treatment outcomes among this population.
Keywords
attendance patterns; rolling group; latent class pattern mixture models; posttraumatic stress
disorder; substance use disorders
Epidemiological and clinical studies have established that the majority of women in
substance abuse treatment have been exposed to interpersonal trauma in their lifetimes
(Dansky, Saladin, Brady, Kilpatrick, & Resnick, 1995; Lincoln, Liebschutz, Chernoff,
Nguyen, & Amaro, 2006; Mills, Lynskey, Teesson, Ross, & Dark, 2005) and commonly
meet diagnosis for co-occurring post-traumatic stress disorder (Brady, 2001; Najavits,
Weiss, & Shaw, 1997). As the extent of such comorbidity and its implications for treatment
have come to light, a number of manualized cognitive behavior therapy approaches have
been developed to address the complex needs of this population with the aim of improving
treatment outcomes.
Empirical support for these cognitive behavioral approaches, such as the Seeking Safety
program (Najavits, Weiss, Shaw, & Muenz, 1998) and substance dependence posttraumatic
stress disorder (PTSD) therapy (Triffleman, 2000), has been promising overall. However,
the lack of well-controlled and sufficiently powered trials combined with small effect sizes
among trials that were controlled (e.g., Hien, Cohen, Miele, Litt, & Capstick, 2004) have
resulted in limited evidence that trauma treatments can significantly impact substance use
outcomes. To date, no single treatment study has shown a magnitude of symptom
improvement such that it could be recommended among guidelines for best clinical practices
among women with co-occurring PTSD and addiction.
As we have detailed elsewhere (Hien, Cohen, & Campbell, 2009), applying conventional
statistical methodologies for randomized controlled trials using an intent-to-treat approach
can be problematic when examining the efficacy of treatments for co-occurring disorders
because of a number of assumptions typically made in group therapy treatment trials for
substance abuse (Feaster, Newman, & Rice, 2003). These assumptions and the ways that
they fail to fit the comorbid PTSD/SUD population are examined and include (a)
homogeneity of patient population and treatment response, (b) a dose–response relationship
between treatment attendance and outcome, and (c) similarity between patient attendance in
groups.
Assumption 1: One Size Fits All
The first assumption is that patients are homogeneous and will have a common treatment
response—that one size fits all (Swift, Callahan, & Levine, 2009). Yet, clinicians and
therapists recognize that women who present for treatment in clinical addictions settings are,
by definition, a heterogeneous group characterized by variation in psychological,
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psychiatric, and social impairments (Greenfield et al., 2007; Stewart, Ouimette, & Brown,
2002). Most randomized trials, however, are designed to examine whether the effects of an
experimental group psychotherapy has a superior effect on a particular set of specified
substance use outcomes relative to a comparison condition, using an intent-to-treat approach
(Feaster et al., 2003). Such approaches typically average across all participants assigned to a
treatment arm and ignore the ways that receipt of the treatments themselves may
differentially affect outcomes.
Assumption 2: More Treatment Attendance Leads to Better Outcomes
The second assumption concerns prevailing clinical and research wisdom in general
psychopathology treatment suggesting a positive dose–response relationship between the
number of sessions attended and salutary treatment response (e.g., 16 –18; Lambert, Hansen,
& Finch, 2001). Given the presenting problems of women with co-occurring PTSD/SUD,
however, there are substantial barriers to treatment entry, regular attendance, and successful
outcomes (Greenfield et al., 2007; Stewart et al., 2002). On average, clinical trials among
women with co-occurring PTSD/SUD retain participants for about half of all scheduled
sessions (Brady, 2001; Hien et al., 2004; Hien, Wells, et al., 2009). Clinical experience
based on previous treatment trials with this population suggests that some traumatized
women, with emotional dysregulation as a core underlying syndrome of PTSD (e.g., Roth,
Newman, Pelcovitz, van der Kolk, & Mandel, 1997), may attend sessions intermittently
(either not attending sequentially or attending over a longer period of time) to titrate the
emotional distress that can be evoked when working with trauma-focused material. Despite
missing consecutive sessions, these women often remain engaged in the treatment process
and stay in contact with their providers and/or study staff. This is particularly true if
intermittent attendance does not interfere with, or even facilitates, positive treatment
outcome among women with this type of comorbidity (e.g., Hien, Wells, et al., 2009).
Indeed, although it remains an open question among women with co-occurring PTSD and
SUD, there is some evidence that number of sessions attended benefits patients up to a
diminishing return in some contexts (Barkham et al., 2006; Feaster et al., 2003).
Assumption 3: Group Membership Attendance Patterns Can Be Considered
Independently From Individual Outcomes
A third assumption involves the independent consideration of group context and individual
outcomes when analyzing treatment group data. The most common modality of
psychotherapy in addictions treatment settings is group therapy with rolling admission
(Morgan-Lopez & Fals-Stewart, 2008a). Yet, most empirical studies have used individual
psychotherapy or closed groups for testing treatment efficacy (Weiss, Jaffe, de Menil, &
Cogley, 2004). By design, participation in group therapy creates a degree of interdependence
among the members; indeed, this is one of the defining and desirable qualities of therapy
groups. Nonindependence among patients in therapy groups makes analysis and
interpretation more complex than methods used to analyze data gathered from individually
based treatments (Bryk & Raudenbush, 1992); this is especially true for open enrollment
groups, where membership may change from session to session (Morgan-Lopez, Saavedra,
Hien, & Fals-Stewart, 2011).
Morgan-Lopez and Fals-Stewart (2008a) detailed four concerns that treatment researchers
should consider regarding the choice of analytic strategy in modeling open enrollment group
data: First, is there a relation between the probability of treatment group attendance and the
(potential) substance use outcome (e.g., patient does not attend treatment because of
relapse)? Second, do treatment effects vary by treatment attendance patterns? Third, do the
subtypes of patients with regard to attendance patterns fluctuate from session to session?
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Fourth, are these fluctuations related to specific points of the calendar (e.g., holidays,
seasons)? The extent to which causal inference is justified in the presence of any of these
issues may depend on how well the analytic strategy handles each element (Morgan-Lopez
& Fals-Stewart, 2006). Failure to consider these elements in rolling group data may obscure
attendance class-specific treatment effects (Morgan-Lopez & Fals-Stewart, 2007) as well as
increase the likelihood of Type I errors (Morgan-Lopez & Fals-Stewart, 2008b). Concerns
about the impact of treatment attendance in and of itself may preclude the examination of
overall treatment outcomes (irrespective of membership turnover) and may warrant a more
nuanced approach to evaluating treatment efficacy and/or effectiveness (Feaster et al.,
2003).
Current Study
The Women and Trauma Study, conducted within the National Institute on Drug Abuse
National Drug Abuse Treatment Clinical Trials Network (NIDA CTN), is the largest
multisite randomized clinical trial to date conducted with women with trauma histories in
community substance abuse treatment. Design features of this trial were selected to
maximize external validity while retaining important internal validity rigor. These features
include (a) psychotherapy, Seeking Safety (Najavits, 2002), with prior evidence of efficacy
and delivered by community treatment counselors (Hien et al., 2004) with high fidelity in an
open enrollment, rolling group format; (b) an attention control group consisting of a health
education curriculum (Women’s Health Education; Miller, Pagan, & Tross, 1998) of similar
length; and (c) assessments, gathered consistently during the treatment period and 1 year
after treatment, that included comprehensive documentation of service utilization.
Primary outcome analyses of the Women and Trauma Study followed an intent-to-treat
approach, which applied hierarchical linear modeling techniques. Overall findings
demonstrated that both group interventions led to significant reductions in PTSD symptoms
during the in-treatment phase. Neither treatment, however, appeared to impact substance use
outcomes differentially over the 1-year follow up period (Hien, Wells, et al., 2009). There
was strong evidence for superiority of Seeking Safety over Women’s Health Education in
reducing risky sexual behavior among those at highest risk (Hien, Campbell, et al., 2010)
and in reducing substance use among those who had significant changes in PTSD symptoms
and were heavy users at baseline (Hien, Jiang, et al., 2010). The lack of more robust
findings, specifically on substance use outcomes, suggests that standard statistical
approaches, which did not account for varying attendance patterns and changing group
membership, may have obscured the impact of the two treatments. Because the trauma-
focused treatment used in the trial was designed to address both PTSD and substance use
outcomes directly and because regulating emotional distress in the trauma treatment should
promote better ability to retain and apply the skills to improve coping with substances,
further examination of the impact of attendance patterns and group membership turnover
specifically on the substance use outcomes is warranted.
Furthermore, there have been advances in the theory of how treatment attendance (Barkham
et al., 2006; Feaster et al., 2003) and group membership turnover (Morgan-Lopez & Fals-
Stewart, 2006, 2008a) impact substance use treatment outcomes and parallel advances in
statistical methodology (Morgan-Lopez & Fals-Stewart, 2007, 2008b) not previously
considered in this area. Newer statistical techniques, such as latent class pattern mixture
approaches (Lin, McCulloch, & Rosenheck, 2004; Roy, 2003), can account for distinctive
missingness/attendance patterns and group membership turnover (in addition to site-level
variation). In the current investigation, we apply these new statistical methods to re-examine
the specific impact of the Seeking Safety group therapy versus Women’s Health Education
from the Women and Trauma Study, taking into consideration attendance patterns and group
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membership turnover on substance use outcomes to further advance the treatments of co-
occurring PTSD and substance use disorders. The following research questions are
examined in this study: First, are there different treatment attendance patterns in this
sample? Second, if so, does one of the patterns involve a titration of treatment frequently
observed among individuals with PTSD and SUD? Third, are there differential substance
use outcomes by treatment type associated with these attendance patterns? We further
speculate that if an attempt to regulate emotional processes underlies a titrator attendance
pattern, this pattern will be (a) more evident among those who received Seeking Safety
compared with the Women’s Health Education group and (b) significantly associated with
better substance use outcomes, when compared with other attendance groups.
Method
Participants
This study used data collected from the NIDA CTN Women and Trauma Study, a
randomized control trial comparing two group interventions for women with PTSD and
SUD. Participants were 353 women enrolled in community-based, intensive, outpatient
substance abuse treatment from seven geographically diverse programs in the United States.
Participants were eligible for the study if they reported at least one lifetime traumatic event
and met Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM–IV;
American Psychiatric Association, 1994) criteria for either full or subthreshold PTSD in the
past 30 days as assessed with the structured Clinician-Administered PTSD Scale (Blake et
al., 1995). Subthreshold PTSD differed from full PTSD only in the number of symptom
clusters that needed to be present; that is, participants had to meet Criterion B (re-
experiencing the trauma) but had to meet only Criterion C (avoidance of trauma reminders)
or Criterion D (hyperarousal) and not both. This is a commonly used definition of
subthreshold PTSD (Blanchard, Hickling, Taylor, Loos, & Gerardi, 1994; Grubaugh et al.,
2005). Other inclusion criteria were (a) being a woman 18 to 65 years of age, (b) using
alcohol or illicit substances within the past 6 months, and (c) meeting a current (within the
prior year) diagnosis of drug or alcohol abuse or dependence. Women were excluded if they
had (a) impaired mental cognition, as indicated by a Mini-Mental Status Exam (Folstein,
Folstein, & McHugh, 1975) score of less than 21, (b) significant risk of suicide or homicide
in the prior 6 months as assessed with the Psychiatric Research Interview for Substance and
Mental Disorders (Hasin, Trautman, & Endicott, 1998), or (c) history of schizophrenia-
spectrum diagnosis or active (past 2 months) psychosis, as clinically assessed using the
Composite International Diagnostic Interview for DSM–IV (Robins et al., 1988). Excluded
participants were referred to clinical services at their treatment programs for more
appropriate intervention.
Recruitment occurred over 21 months in 2004 and 2005. Female clients enrolled in the
community treatment program were approached and informed of the study. If interested and
willing, clients completed a brief eligibility assessment. Those meeting major eligibility
criteria were then formally assessed in a two-part screening and baseline interview. After the
baseline assessment, participants were randomized into either Seeking Safety or Women’s
Health Education treatment groups; each site received 60 sealed, tamper-evident, opaque
envelopes generated by an independent statistician containing a randomization number
corresponding to treatment assignment. Women completed brief, weekly assessments for
substance use, PTSD symptoms, and service utilization during treatment and were
reassessed with the full assessment battery 1 week, 3, 6, and 12 months posttreatment.
Independent assessors administered baseline and follow-up assessments; they were unaware
of study randomization, and participants were reminded before each follow-up assessment
that the independent assessor should not have knowledge of their study condition. Informed
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consent was completed for the screening assessment, with study informed consent gathered
prior to baseline. The study was approved by the institutional review board representing the
coordinating site as well as at each individual treatment site. Table 1 includes information on
demographics, baseline PTSD and SUD diagnoses, and traumatic experiences by treatment
condition.
Study Treatments
Prior to attending groups, participants met individually with the group leader to receive an
introduction to the treatment and review group rules. Treatment consisted of two 90-min
sessions per week for 6 weeks. Groups ranged in size from two to eight women and operated
with an open, rolling admission so that participants could enter the group at any point in the
12-session cycle (i.e., a participant might start with Session 7 and complete treatment with
Session 6). Participants remained in study treatment regardless of attendance unless they
missed four consecutive sessions with no study contact. Those who missed sessions were
given the opportunity to review content by viewing a videotape of the missed group or
groups, but this was not considered the same as attending a session. Participants were also
terminated from study treatment if they withdrew from the treatment program.
Study treatments had different foci based on different theoretical orientations and
hypothesized mechanisms of change (see the primary outcome article, Hien, Wells, et al.,
2009, for more on distinguishing among treatments). Briefly, the Seeking Safety treatment
(Najavits, 2002) is a short-term manualized therapy (group or individual modality) utilizing
cognitive behavioral strategies to reduce substance use and the negative impact of trauma
exposure. Sessions are structured and include education on substance use disorders and
PTSD, skills to prevent drug use and control PTSD symptoms, cognitive restructuring with
particular attention to maladaptive thoughts associated with substance use and trauma
symptoms, and a focus on building a healthy support network through the development of
effective communication skills. Session topics are meaningfully connected to participant
reports of both unsafe behavior and coping skills. The group format allows women to
provide support and reinforcement to each other.
Women’s Health Education (Miller et al., 1998) is a psychoeducational intervention that
focuses on topics such as female anatomy, human sexual behavior, pregnancy and
childbirth, nutrition, and diabetes. Women’s Health Education provides equivalent facilitator
attention, expectancy of benefit, and issue oriented focus but does not provide theory driven
techniques, such as cognitive behavioral therapy and psychoeducation specific to substance
abuse and PTSD. Topic presentations use minilecture, video, storytelling, and/or text
readings as well as exercises to facilitate group discussion and application of materials.
Treatment Fidelity
Counselors and supervisors were selected from each site on the basis of willingness to be
randomized to one of the two intervention conditions and demonstrated ability to deliver a
manualized, cognitive behavioral style of therapy based on review of an audiotaped relapse
prevention session. Following centralized training, counselors and supervisors were certified
in the interventions after completing a training group of at least four sessions and meeting
adequate adherence levels. During study implementation, all intervention sessions were
videotaped, and approximately 50% were rated for adherence by local supervisors;
counselors met weekly with supervisors. Intervention experts at the coordinating site co-
rated a randomly selected quarter of the counselor session tapes reviewed by the supervisor
to monitor reliability on adherence measure scores (see Hien, Wells, et al., 2009, for
additional information on adherence measures and interrater reliability).
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Substance use—Information on alcohol and cocaine use was collected at each of the
assessment time points, using the Addiction Severity Index (ASI-Lite, revised from the 1997
ASI, Fifth Edition; McLellan, Alterman, Cacciola, Metzger, & O’Brien, 1992). Participants
reported the number of days (0 –30) on which any of these substances were used. Because
we were interested in treatment effects on any use, binary indicators were created at each
time point from these measures. The ASI has demonstrated reliability and validity across
diverse substance-using populations (Samet, Waxman, Hatzenbuehler, & Hasin, 2007).
Additional measures—Measures that were beyond the scope of this study were also
administered and included measures of sociodemographics, PTSD frequency, and PTSD
intensity. These are discussed in Hien, Wells, et al. (2009).
Data Analytic Approach
As noted elsewhere (Morgan-Lopez & Fals-Stewart, 2006, 2007, 2008a, 2008b), standard
analytic approaches used for modeling treatment outcomes (e.g., repeated measures analysis
of variance, group-clustered latent growth models) have limited utility in accounting for the
changes over time in treatment group membership that occur within open enrollment groups
(i.e., loss and addition of group members). Latent class pattern mixture modeling (LCPMM;
Lin et al., 2004; Roy, 2003; see also Muthén, Jo, & Brown, 2003) has been shown in both
real (Morgan-Lopez & Fals-Stewart, 2007) and simulated treatment outcome data (Morgan-
Lopez & Fals-Stewart, 2008b) to be a promising approach for modeling specific nuances of
the open enrollment group process (i.e., group membership turnover, latent attendance
classes within treatment groups).
LCPMMs (a) account for variability in the treatment effect across a finite number of latent
attendance classes among individuals in the same treatment group and (b) can be structured
to model relations between attendance class membership and variation in patients’ points of
entry into treatment. The logic underlying the utility of LCPMMs to the analysis of data
from substance abuse treatment trials with rolling/open enrollment groups is that, within any
point of the trial, the proportions of different types of attendance patterns (and, therefore,
different subtypes of patients) are allowed to vary at any given slice in time at which the trial
is running (Morgan-Lopez & Fals-Stewart, 2007, 2008a). Moreover, group composition and
norms change over time in concert with changes in the membership of the group, which
collectively may affect the efficacy of the treatment during particular periods of the history
of the group (e.g., the proportion of dropouts decreases over time as the group becomes
more cohesive and efficacious).
The focal point of the LCPMM model is a categorical latent variable (called Attend in
Figure 1), which captures the estimated probabilities of membership in one of a finite
number (C) of latent classes (e.g., Attend = 1, 2 … C). This variable represents multiple
latent subpopulations within treatment outcome data, which vary between classes along
three sets of variables (see Figure 1). First, classes can vary in their probabilities of
treatment attendance at each session, through a series of binary indicators of whether each
patient showed up for treatment at week w (0 = no show, 1 = show) beyond the initial
session for each person. Second, differences may emerge on the distributions of the timing
of treatment entry (i.e., Start Week), which (a) may show fluctuations over time in the
proportions of patients from each subpopulation and (b) may be indicative of variation in the
makeup of treatment groups that is dependent on calendar time (Morgan-Lopez & Fals-
Stewart, 2007, 2008b). Finally, differences across the classes may emerge on the effect of
the treatment condition (Seeking Safety/Women’s Health Education) on growth over time in
the outcome for the in-treatment interval (βITI) and posttreatment interval (βPTI) slopes that
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underlie the substance use outcome measures (ybaseline–y12 month); differences in the
intercept (αITI) by treatment condition are also possible, though they would, of course, be
indicative of undesirable differences at baseline.
If there is more than one class, the growth parameters (i.e., conditional growth parameter
means, treatment effects) from each class are averaged and weighted by the class
proportions, and standard errors are calculated using the delta method (see Hedeker &
Gibbons, 1997, pp. 74 –76; Morgan-Lopez & Fals-Stewart, 2007, p. 593) in order to
estimate the overall treatment effect; note that this weighted averaging can now be
conducted within a single step within an LCPMM analysis (e.g., with the Model Constraint
command in Mplus v5.2). Both overall and class-specific treatment effects are presented
here.
Results
Preliminary Identification of Functional Form
The group stratified finite mixture modeling facilities within Mplus 5 (Muthén & Muthén,
1998 –2009) were used for all analyses under robust maximum likelihood estimation (i.e.,
Mplus MLR estimation under stratification; Asparouhov, 2005). Prior to fitting the models
of interest, the observed proportions for alcohol and cocaine use across preintervention and
the four follow-up assessments were plotted to get a sense of the optimal functional form;
assessing the correct functional form (i.e., latent variable structure) a priori also minimizes
the likelihood of overextraction of latent classes (Bauer & Curran, 2004). We concluded, on
the basis of the graphical analyses, that the optimal functional form for the two substances
was piecewise linear with two distinct periods of growth: (a) growth from preintervention to
1-week posttreatment follow-up and (b) growth from 1-week through 12-month
posttreatment follow-up. The time steps for each of these three growth parameters (intercept,
first slope, second slope) were structured such that the intercept was set at preintervention
(i.e., estimated level probability of use in the week prior to the participant’s first treatment
session).
Graphical analyses were supplemented by a series of unconditional growth models (with
probit link functions for categorical outcomes for this and all subsequent analyses) examined
under alternate functional forms. When we used chi-square difference testing, the fit of the
unconditional two-piece piecewise linear model described earlier did not differ significantly
from unconditional models that included a quadratic growth factor for growth during the
posttreatment phase (Δχ2 for both substances was at or exceeded p = .10). Thus, the two-
piece piecewise linear functional form was used for all subsequent analyses.
Identification of the Optimal Number of Attendance Classes
Next, a series of two-piece linear probit LCPMMs (under group stratification for
nonindependence because of site-level clustering), with varying numbers of latent
attendance classes, was fit to determine the optimal number of classes. Bayesian information
criterion (BIC) and entropy were used to determine the optimal number of classes. As shown
in Table 2, the BIC suggests three classes are optimal across each of the substances (from
the perspective of model fit); however, the two-class solutions produced entropy values that
were best. We chose the three-class solution(s) because BIC is more closely tied to model fit
(i.e., omission of classes) than is entropy (classification quality), though these measures tend
to agree in practice.
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Probabilities of treatment attendance across classes—Across the two sets— one
for alcohol use, one for cocaine use— of three-class LCPMM analyses, a similar pattern
emerged for treatment attendance (only patterns from the alcohol model are shown, to avoid
redundancy). The first class, completers, never decreased below an 80% probability of
treatment attendance; the class membership (based on posterior probabilities of class
membership as opposed to the most likely class assignment) was between 47% and 48% of
the total sample across both substances. The second class under the three-class models is
called droppers. This class never exceeded a 41% probability of attending treatment, and by
the fourth session they would have attended, they had virtually 0 probability of attendance
for the remainder of the protocol; this class made up around 24% of the sample across all
substances/models. The third class is referred to as the titrators class; through the seventh
session, these patients ranged between a 50% and an 80% probability of attending treatment,
with further decreases in the probability of showing up for treatment across sessions but
with probabilities that never approached 0 as in the droppers class; this class ranged between
27% and 28% of the sample across the substances/models. In both LCPMM analyses,
treatment condition was not predictive of attendance class membership such that the
proportion of completers, titrators, and droppers did not differ significantly for the Seeking
Safety condition or the Women’s Health Education condition (e.g., p values were all greater
than .17).
Across the classes, pretreatment differences among participants along sociodemographic and
clinical variables, including age, race, education, symptoms of depression, paranoid
ideation, and 12-step affiliation, were nonsignificant at the individual level as estimated in
separate mixture models. However, at the group level (i.e., variation in the percentages of
patients within each class across treatment groups; N = 12 treatment groups), groups with
higher proportions of (eventual) dropouts had greater group mean levels of baseline
psychiatric problems ( p = .013) and family problems ( p = .023). Conversely, treatment
groups with higher proportions of (eventual) titrators had lower group mean levels of
psychiatric problems ( p = .002), family problems ( p = .09), depression ( p < .001), and
paranoid ideation ( p = .07).1
Distributions of the month of trial entry—The histogram (alcohol model only) in
Figure 2 shows fluctuation in the number of patients within each class in the three-class
model(s) throughout the span of the trial across 22 months. As noted earlier, the overall split
in class membership was around 48% completers, 24% droppers, and 28% titrators based on
the sums of posterior probabilities of class membership. Prior to Month 10, droppers made
up 26% of the sample, but they made up only 18% of the sample beyond Month 10,
suggesting lower dropout probabilities during the second half of the trial; conversely,
titrators made up 21% of the sample from Months 1 through 10 and increased to 26%
beyond Month 10, which may be suggestive of greater treatment retention as the trial moved
forward in calendar time.
Effect of Attendance Class and Treatment on Alcohol Use (See Table 3 and Figure 3)
Completers—Among completers, there were significant decreases in the probability of
alcohol use (as evidenced by logistic regression coefficients) from baseline to 1-week post-
treatment follow-up, b = −1.334 (0.542), t = −2.463, p = .014, followed by nonsignificant
increases in alcohol use from 1-week through 12-month follow-up, b = 0.215 (0.744), t =
1Psychiatric and family problems were assessed using composite scores compiled from two domains on the ASI-Lite (McLellan et al.,
1992). Depression and paranoid ideation symptom scores were derived from subscales on the Brief Symptom Inventory (Derogatis,
1993).
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0.289, p = .77. Neither the in-treatment nor the posttreatment slopes ( p = .26 and p = .09,
respectively) differed between completers in the Seeking Safety condition and the Women’s
Health Education condition.
Droppers—Among droppers, there were nonsignificant increases in alcohol use from
baseline to 1-week follow-up, b = 0.446 (1.210), t = 0.368, p = .71, followed by
nonsignificant increases in alcohol use from 1-week through 12-month follow-up, b = 0.119
(0.815), t = 0.146, p = .88. Neither the in-treatment nor the posttreatment slopes ( p = .64
and p = .92, respectively) differed between droppers in the Seeking Safety condition and the
Women’s Health Education condition.
Titrators—Among titrators, there were nonsignificant decreases in alcohol use from
baseline to 1-week follow-up, b = −1.531 (1.056), t = −1.449, p = .14, followed by
nonsignificant increases in alcohol use from 1-week through 12-month follow-up, b = 0.463
(0.740), t = 0.626, p = .53. Although the in-treatment slopes did not differ between Seeking
Safety and Women’s Health Education (p = .94), patients in Seeking Safety had lower rates
of alcohol use from 1-week through 12-month follow-up compared with Women’s Health
Education, b = −0.203 (0.085), t = −2.389, p = .017.
Effects averaged across classes—When combined across classes, no differences in
treatment effects on alcohol use were observed between Seeking Safety and Women’s
Health Education. Contrasts were conducted to assess whether treatment effect differed
across classes (e.g., treatment effect for completers vs. droppers); none of those contrasts
were significantly different from 0 (all ps > .65).
Effect of Attendance Class and Treatment on Cocaine Use: All Classes
Among all classes, nonsignificant decreases in cocaine use were observed during the in-
treatment and posttreatment phase; these decreases did not differ between Seeking Safety
and Women’s Health Education.
Discussion
The extant literature has produced a limited number of multisite effectiveness trials that
consider the influence of attendance patterns and membership turnover on outcomes for
group psychotherapy with rolling admission. The present study took important initial steps
to address this gap through a secondary analysis of recently published clinical trial data
(Hien, Wells, et al., 2009), using innovative statistical approaches to examine the impact of
attendance patterns and more accurately model rolling admissions groups on in-treatment
and posttreatment substance use outcomes. We were interested in drawing from an
emotional regulation perspective of PTSD and SUD to examine whether varying patterns of
treatment attendance would reveal treatment-specific differences in outcomes on substance
use over time.
With respect to the first research questions, findings are consistent with three treatment
attendance patterns distinct by their probabilities of session attendance across 6 weeks of
treatment (Figure 4). Specifically, across our heterogeneous multisite sample, three different
attendance patterns were identified: patients who tended to have at least an 80% probability
of attending sessions (completers), participants who tended to discontinue treatment by the
fourth session (droppers), and patients whose tendency was to have a high probability of
attending group through their seventh session but then showed sporadic attendance
thereafter (titrators).
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Thus, with respect to the second research question, there does appear to be a class of
participants whose attendance is consistent with titration of treatment, that is, participants
who have significant numbers of missed sessions but do not appear to fully terminate
treatment engagement. With respect to the third research question, when attendance patterns
were jointly modeled with substance use outcome trajectories in this secondary analyses,
important differential treatment effects emerged that were previously undetected. As
hypothesized, benefits for the trauma-focused treatment were most evident among the
titrators class. Titrating patients showed reductions over time in substance use outcomes in
the Seeking Safety condition compared with Women’s Health Education, a finding that had
not been observed using conventional longitudinal modeling methods (e.g., hierarchical
linear models) for the substance use outcomes (Hien, Wells, et al., 2009).
Notably, however, although findings for cocaine were in a similar direction, only alcohol
use outcomes reached a level of statistical significance. Our findings underscore the
importance of considering dose–response (albeit latent in this case) and treatment group
composition to better identify for whom and to what degree a specific treatment might work
(Stulz, Lutz, Leach, Lucock, & Barkham, 2007). Results suggest that the number of sessions
attended might not be as useful as the quality of the participation for this PTSD and SUD
population. For titrators who received Seeking Safety, attendance through the seventh
session might have been an optimal or good enough level in terms of dose responsiveness
(Barkham et al., 2006). Further, they appeared to be able to apply what they learned in
treatment over a 12-month follow-up period. Conversely, there was no evidence to suggest
that those who attended and received more Seeking Safety sessions derived additional
benefit from the greater dose of therapy. This is also consistent with a relatively large body
of research indicating that the “level of improvement and treatment duration are mutually
regulated so that treatments tend to end when clients, on average, have improved to a degree
or level that is good enough” (Barkham et al., 2006, p. 161). Relatedly, in one of the earliest
studies of Seeking Safety among women outpatients, Najavits et al. (1998) found that
treatment completers were actually more impaired than dropouts and had a worsening of
somatic symptoms posttreatment, suggesting that treatment completion may not always be
beneficial.
Of note, results comparing titrators and completers revealed no statistically significant
differences on any individual level severity (PTSD or substance use disorders) or
demographic correlates. That is, neither titrators nor completers appeared to be more
severely impaired. However, further analyses of the group context did detect relevant
differences. Specifically, treatment groups with a larger proportion of titrators had members
with more medical problems but also lower baseline levels of anxiety, depression, and self-
reported symptoms of paranoia compared with groups made up of more completers. Thus,
we could also speculate that members of titrator groups might have had more barriers to
attendance (e.g., more medical problems) but, when attending treatment, were in groups
with other patients who had less severe psychopathology and were overall more able to
profit from the treatment content and process.
Among those in the Women’s Health Education groups, completers derived a similar benefit
on alcohol outcomes to the titrators in the Seeking Safety groups. This treatment effect
suggests that the type of treatment offered in the group context also differentially affects
outcomes when group membership characteristics are considered. Among those receiving a
non-trauma-focused treatment, even when groups had more psychiatric comorbidity, there
was still a benefit of the group therapy for substance outcomes for these participants. This
finding suggests that important nonspecific therapeutic factors, such as support, consistency,
and a safe therapeutic environment (Moos, 2007; without the added trauma content), were
differentially beneficial for these patients in terms of alcohol use outcomes. It is also
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possible that the psychoeducational component of the health education group had specific
therapeutic effects on alcohol use outcomes. Studies indicate that, given the deficits in self-
care often evident in individuals with substance use disorders, the provision of accurate and
comprehensible information about specific health issues can lead to positive treatment
outcomes (Cummings & Cummings, 2008; La Salvia, 1993).
Across groups and membership patterns, only one of the groups during the in-treatment
phase differed from the others. Among those in the Women’s Health Education groups with
more droppers, alcohol outcomes were significantly worse than those of all other groups,
whose alcohol use diminished over the treatment phase. In light of the fact these groups did
receive substance abuse coping skills, it is not surprising that those who dropped out of
treatment early and received few-to-no sessions of any skill-based approach to managing
substance use would have poorer outcomes overall. Because our study was the first to begin
disentangling attendance-specific effects for an active treatment and active comparison,
subsequent studies are needed to dismantle these effects.
Limitations
The present study had certain limitations, and it is important to be cautious in interpreting
the results. First, additional service utilization was not taken into account in this analysis.
Similarly, although we have presented elsewhere that PTSD improvements were
differentially associated with substance use reductions among more severely ill participants
(Hien, Jiang, et al., 2010), this analysis did not incorporate PTSD symptom changes or
directionality in comorbidity (i.e., primary vs. secondary PTSD), as the complexity of that
analysis was beyond the scope of this article. Also, because we did not directly measure
emotional regulation, we can only speculate that titrators’ intermittent attendance was
related to attempts to adaptively manage emotional distress or activation and that better
regulation in this group may have led to superior outcomes when receiving the trauma
therapy. For example, an alternative explanation for the pattern of attendance among the
titrators could be a result of participant’s perception of value of the treatment, but this was
not measured and so could not be determined. Although completers appeared not to benefit
further with regard to alcohol or cocaine use than the titrators, there may have been other
factors that were neither measured nor analyzed that induced completers to receive the
maximum dose that could help to explain this finding. Another measurement limitation of
note is that substance use outcomes were based on self-report and did not account for
changes in quantity of use (e.g., standard drink units). Finally, because this was a voluntary
study, not all eligible participants chose to enroll, reducing generalizability of results.
Limitations notwithstanding, there are several strengths of the present study, which make
important contributions to the literature. These include our use of a heterogeneous patient
population, use of a relatively large sample, and analytic provisions to account for site-level
variation, group membership turnover, and consideration of treatment dose in analyses. This
analysis expanded the addiction measures beyond those used in the primary outcome article
(Hien, Wells, et al., 2009) to include substance-specific use outcomes from the ASI-Lite,
common in addiction studies.
Implications and Future Directions
This reanalysis of the Women and Trauma Study randomized multisite trial provides a new
model for considering how to account for participant-driven attendance patterns and rolling
groups, both in analysis and interpretation of treatment results. It specifically lends support
to the importance of considering emotion regulatory processes and treatment titration among
those with PTSD and SUD. Those interested in translational research, which in part
examines how psychotherapeutic treatments fare in community-based settings, must
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consider a priori these kinds of analyses in order to illuminate potentially subtle yet
clinically relevant differences based on how a patient attends a treatment and who else is
attending with them. Future studies should attend to specific design issues to account for
site-specific factors that may influence outcomes associated with delivery of treatment, as
well as assess the effect of concurrent service utilization. Because of the rolling group
design, we selected 12 sessions of Seeking Safety to be free standing, assuming that session
content is independent from treatment dose. However, it is quite possible that order of
sessions received may also impact treatment efficacy. Future research should focus on this
complex analysis in fuller detail.
Beyond implications for research, findings suggest potentially valuable directions to
improve standard of care for women with PTSD and comorbid SUD. In line with the
concepts of personalized medicine, our findings underscore the importance of individualized
treatment planning versus standardized decisions about treatment attendance, treatment
duration, and primary substance of abuse within community-based substance abuse recovery
programs. Treatment programs may benefit from lessening the emphasis on very high
attendance rates and target interventions and program policies that recognize that attendance
rates of 50% to 80% may confer equal or even greater benefit. More fundamentally, these
study findings should prompt providers to consider that female patients with comorbid
PTSD and SUD may be in the best position to determine when, how often, or which sessions
to attend; such perspectives might not only be empowering to patients but might be
efficacious as well.
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Latent class pattern mixture model: yb–y12mp = Binary indicators of substance use from
baseline through 12-month follow-up; SS/WHE = treatment condition (Seeking Safety = 1;
Women’s Health Education = 0); αITI = estimated level of the outcome at time = 0; βITI =
estimated rate of change from baseline to immediate posttreatment (in-treatment interval);
βPTI = estimated rate of change from immediate posttest through 1-year follow-up.
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Latent class membership histogram across calendar time.
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Predicted probability of alcohol use over time by treatment group (Seeking Safety or
Women’s Health Education) and latent class membership.
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Attendance probabilities by latent class.
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Table 1
Baseline Participant and Diagnostic Characteristics by Treatment Group (N = 353)
Variable Total Seeking Safetya (N = 176) Women’s Health Educationa (N = 177)
Age (years) 39.2 (9.3) 39.3 (9.5) 39.0 (9.1)
Race/ethnicity
 African American/Black 34.0 33.0 35.0
 Caucasian 45.6 47.2 44.1
 Latina 6.5 4.0 9.0
Multiracial/other 13.9 15.9 11.9
Education (years) 12.5 (2.4) 12.7 (2.3) 12.4 (2.6)
Employment
 Employed 40.2 40.3 40.1
 Unemployed 55.0 54.6 55.4
 Student/retired/disabled 4.8 5.1 4.5
Current abuse or dependence diagnosis
 Cocaine 70.5 72.7 68.2
 Stimulants 7.7 8.5 6.8
 Opiates 25.6 25.6 25.6
 Marijuana 27.2 27.8 26.6
 Alcohol 56.1 59.7 52.5
PTSD diagnosis (% meeting full criteria) 80.4 76.7 84.2
Lifetime traumatic experiences
 Child physical abuse 58.7 61.1 56.3
 Adult physical abuse 84.8 83.4 86.2
 Child sexual abuse 70.1 73.6 66.7
 Adult sexual abuse 67.6 65.1 70.1
 Transportation accident 72.7 72.2 73.3
 Life-threatening illness 39.8 41.5 38.1
 Exposed to violent death 19.3 16.5 22.2
Note. Values are means (with standard deviations in parentheses) unless otherwise noted. PTSD = posttraumatic stress disorder.
a
There were no statistical differences between treatment groups on any variable.






















Note. BIC = Bayesian information criterion.
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